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ABSTRACT 
This study presents a novel microfluidic approach for developing large scale screening assays of 
anticancer compounds on 3D multicellular spheroids.  We have developed a microfluidic device with 
associated protocols that combine the high-throughput characteristics of droplet microfluidics for 
spheroid formation and aggregation with those of single-phase microfluidics for substance exchange, 
long term culture and drug perfusion. 
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INTRODUCTION 
In the past decade, there has been an increase in the identification of potential anticancer drugs.   
However, less than 10% are approved  after clinical trials[1].  One of the major issues is the 
unsuitability of the in vitro models used in preclinical settings.  The use of 3D cell culture models, 
such as those based on multicellular tumour spheroids, is expected to provide a more accurate 
reflection of the tumour microenvironment in vivo.  Currently used spheroid formation techniques 
suffer from several limitations, such as being labour intensive and low throughput.  Emulsion based 
technologies can overcome such disadvantages by offering increased mechanical stability and high 
throughput methodologies through miniaturisation via droplet microfluidics.  However, a drawback of 
the technology for cell culture is compartmentalization and we have previously shown the related 
challenges and detrimental effects involved in medium exchange and delivery of compounds[2].   
Therefore, microfluidic solutions must provide access to the encapsulated cellular environment and 
typically these are based on double emulsions and gel particles[3], [4], conditions that increase the 
complexity of the microfluidic setup. 
 
EXPERIMENTAL 
In this study, we present a microfluidic device based on a passive channel network[5], [6] that 
uses first droplet microfluidics to create and position spheroids in predefined locations and, 
subsequently, induces destabilization of the emulsion interface without compromising the cell culture 
conditions, transitioning from segmented flows to single-phase flows (Figure 1).  It was discovered 
that the properties of cell culture medium caused coalescence of the emulsion interface without 
reducing the surfactant concentration.  This mechanism was exploited to coalesce droplets containing 
spheroids, thus allowing for substance exchange (Figure 1C). 
 
 
Figure 1: (A) Design of microfluidic device with oil inlet (1A); aqueous phase inlet (2A); air bypass 
channel (3A); outlet (4A) and chamber array (5A). (B) Brightfield images showing the trapping of 
droplets (1) and the bypassing of a droplet to fill the next trap (2 to 4). (C) Brightfield and fluorescent 
images showing the coalescence of a long plug containing calcein with trapped droplets only 
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RESULTS AND DISCUSSION 
We used UVW glioma cells to initially create spheroids within droplets, taking advantage of the 
non-adherent interface features created by the PEG-fluorosurfactants2.  The oil-medium interface was 
controllably coalesced to allow for long term culture, as well as medium and compound perfusion 
such as drugs and viability stains.  Spheroids (64 per device) were cultured for up to 17 days with no 
detrimental effects and their viability confirmed using live/dead staining (Figure 2).  Furthermore, 
proof-of-concept treatment of spheroids with anticancer compounds was carried out using cisplatin, 
producing a significant reduction in spheroid growth.  Preliminary experiments also showed that it 
was possible to use the device for the formation of alginate beads for the culture of spheroids. 
 
 
Figure 2: (A) Time-lapse of bright-field images of a spheroid within a trapping site terminating with a 
fluorescent image showing spheroid staining by fluorescein diacetate (green) and propidium iodide 
(red) on day 17. (B) Growth curve of average spheroid diameter (ʅm) ± standard error of the mean 
(error bars) over 14 days for a control and treated (50 ʅM of cisplatin) spheroid populations.** 
indicates a p value of less than 0.01.The scale bar is 200 ʅm. 
 
CONCLUSION 
Overall, we have developed a microfluidic system for the long term culture of multicellular 
spheroids formed within aqueous droplets and alginate beads which is suitable for chemotherapy 
treatment.  In the future, this device has the potential to be used for the screening of spheroids formed 
from biopsy samples for development of personalised combination therapies. 
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